Capricor Therapeutics (CAPR) Q3 2023 Earnings

14NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.35
-0.32
-0.28
-0.25

Details

Expected EPS
-0.29
Actual EPS
-0.25
Surprise EPS
0.04
Surprise Percent
+13.79%

Description

Capricor Therapeutics (CAPR) has reported earnings of -0.25 per share for Q3 2023.

0 Comments

Share your thoughts